Nikom Pharma Mktg Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -286.50%
(FY 2020)
- Ebitda -165.39%
(FY 2020)
- Net Worth -14.21%
(FY 2020)
- Total Assets -4.09%
(FY 2020)
About Nikom Pharma Mktg
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayant Mirani, Nastasia Mirani, and Komal Jayant serve as directors at the Company.
- CIN/LLPIN
U51102MH2003PTC141174
- Company No.
141174
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nikom Pharma Mktg?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nastasia Mirani  | Director | 15-Dec-2018 | Current |
| Komal Jayant | Director | 10-Apr-2018 | Current |
| Jayant Mirani | Additional Director | 08-Nov-2021 | Current |
Financial Performance of Nikom Pharma Mktg.
Nikom Pharma Mktg Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 286.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nikom Pharma Mktg?
Unlock access to Nikom Pharma Mktg's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nikom Copper And Conductors Private LimitedActive 7 years 10 months
Jayant Mirani is a mutual person
- Nikom Laboratories Private LimitedActive 32 years 5 months
Jayant Mirani, Nastasia Mirani and 1 more are mutual person
Stellar Marine Food Processor India Private LimitedActive 28 years 5 monthsJayant Mirani is a mutual person
- Stellar Marine Foods Private LimitedActive 12 years 4 months
Nastasia Mirani and Komal Jayant are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nikom Pharma Mktg?
Unlock and access historical data on people associated with Nikom Pharma Mktg, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nikom Pharma Mktg, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nikom Pharma Mktg's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
